S

Seegene Inc
KOSDAQ:096530

Watchlist Manager
Seegene Inc
KOSDAQ:096530
Watchlist
Price: 25 500 KRW -1.54%
Market Cap: 1.3T KRW

Wall Street
Price Targets

Price Targets Summary
Seegene Inc

Wall Street analysts forecast Seegene Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Seegene Inc is 43 860 KRW with a low forecast of 42 420 KRW and a high forecast of 46 200 KRW.

Lowest
Price Target
42 420 KRW
66% Upside
Average
Price Target
43 860 KRW
72% Upside
Highest
Price Target
46 200 KRW
81% Upside
Seegene Inc Competitors:
Price Targets
DTIL
Precision BioSciences Inc
339% Upside
MNKD
MannKind Corp
83% Upside
BBIO
BridgeBio Pharma Inc
25% Upside
CVAC
CureVac NV
9% Downside
EDIT
Editas Medicine Inc
46% Upside
MDGL
Madrigal Pharmaceuticals Inc
6% Upside
TPST
Tempest Therapeutics Inc
14% Downside
068270
Celltrion Inc
28% Upside

Revenue
Forecast

Revenue Estimate
Seegene Inc

For the last 12 years the compound annual growth rate for Seegene Inc's revenue is 19%. The projected CAGR for the next 3 years is 16%.

19%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Seegene Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Seegene Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Seegene Inc's stock price target?
Price Target
43 860 KRW

According to Wall Street analysts, the average 1-year price target for Seegene Inc is 43 860 KRW with a low forecast of 42 420 KRW and a high forecast of 46 200 KRW.

What is Seegene Inc's Revenue forecast?
Projected CAGR
16%

For the last 12 years the compound annual growth rate for Seegene Inc's revenue is 19%. The projected CAGR for the next 3 years is 16%.

Back to Top